Trial Profile
A clinical trial of ATB-200 in pediatric patients with Pompe disease
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 20 Sep 2018
Price :
$35
*
At a glance
- Drugs Cipaglucosidase alfa (Primary)
- Indications Glycogen storage disease type II
- Focus Therapeutic Use
- Sponsors Amicus Therapeutics
- 20 Sep 2018 New trial record
- 10 Sep 2018 According to an Amicus Therapeutics media release, this trial is anticipated to begin in 2019.